Urology News and Research

Latest Urology News and Research

Majority of men on ADT after prostatectomy gain weight during first year of therapy

Seventy per cent of men who received androgen-deprivation therapy (ADT) after surgery to remove their prostate gland gained significant weight in the first year, putting on an average of 4.2kg, according to a paper in the March issue of the urology journal BJUI.

11 Mar 2011

Surgical robot acquisition increases rate of surgery to treat prostate cancer

A new study conducted by researchers at NYU Langone Medical Center and Yale School of Medicine shows that when hospitals acquire surgical robotic technology, men in that region are more likely to have prostate cancer surgery. The study, "The Association between Diffusion of the Surgical Robot and Radical Prostatectomy Rates", was published this week in the online edition of the journal Medical Care.

11 Mar 2011

State roundup: Concerns about pay for Mass. health executives, board members

Health insurers Harvard Pilgrim Health Care and Tufts Health Plan said yesterday that their board members will meet later this month to discuss whether to bow to state Attorney General Martha Coakley's wishes and stop taking five-figure annual payments.

11 Mar 2011

TARIS commences LiRIS Phase 1B clinical study in interstitial cystitis

TARIS Biomedical, a specialty pharmaceutical company pioneering the development of innovative, targeted therapies using drug delivery to treat bladder diseases with high unmet medical need, announced that it has initiated a Phase 1B clinical study in patients with interstitial cystitis (IC). The study will evaluate the safety and tolerability of TARIS' innovative product candidate LiRIS® in patients suffering from moderate-to-severe IC.

10 Mar 2011

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced it has reached the target enrollment for the double-blind placebo-controlled phase III program of XIAFLEX for the treatment of Peyronie's disease.

9 Mar 2011

Vermillion's CA125 positive preliminary data against ovarian tumors presented at WCSGO

Vermillion, a molecular diagnostics company, today announced the presentation of positive preliminary data from its collaboration with Johns Hopkins University School of Medicine to identify biomarkers that improve on the specificity of CA125 for the identification of malignant ovarian tumors.

9 Mar 2011

Lab made urinary tube going strong after six years of transplant

In a scientific breakthrough, five boys who were unable to urinate due to pelvic injury were cured for up to six years after getting new lab-grown urethras or urinary tubes that connect with the bladder. This breakthrough comes from Wake Forest University researcher Anthony Atala. It was in 2006 that the team reported the first successful implantation of lab-grown urinary bladders into humans. Today six years after the operation all of the boys continue to do well, with normal or near-normal urinary flow. The boy first treated is now 16 years old and received his lab-grown urethra over six years ago.

8 Mar 2011

University of California, Irvine purchase SpineAssist to conduct minimal invasive surgeries

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, announced today that the University of California, Irvine Medical Center has purchased SpineAssist, Mazor Robotics' surgical robotic system that enables surgeons to conduct minimally invasive and complex spine surgeries in a safe and accurate manner.

8 Mar 2011

Scientists develop innovative device to efficiently identify CTCs in blood

Circulating tumor cells, which play a crucial role in cancer metastasis, have been known to science for more than 100 years, and researchers have long endeavored to track and capture them.

8 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

Study: Men who consume non-steroidals more likely to have erectile dysfunction

Men who take non-steroidal anti-inflammatory drugs three times a day for more than three months are 2.4 times more likely to have erectile dysfunction compared to men who do not take those drugs regularly, according to a Kaiser Permanente study published online in The Journal of Urology.

3 Mar 2011

Novabay commences NVC-422 catheter Phase 2 trial to treat UCBE

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today provided an update on its Phase 2 clinical trial for the use of its lead compound, NVC-422, to prevent urinary catheter blockage and encrustation which is often a contributing factor to urinary tract infections in chronically catheterized patients.

2 Mar 2011

UH Ahuja Medical Center officially opens its doors to patients on March 2

University Hospitals Ahuja Medical Center – the first new stand-alone hospital in Cuyahoga County in 30 years –officially opens its doors to patients on March 2.

2 Mar 2011

Robotic surgery offers better results than laparoscopic procedures for kidney disease

Robotic surgery offers the same or better results than minimally invasive laparoscopic procedures for treating kidney disease, and can potentially help more patients because it is not as difficult for surgeons to learn, according to a new study led by Henry Ford Hospital specialists.

2 Mar 2011

Robotic surgery offers favourable outcomes in patients with kidney disease

2 Mar 2011

Endo fourth quarter total revenues increase 31% to $511 million

Endo Pharmaceuticals today reported financial results for the fourth quarter 2010.

28 Feb 2011

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

As a world leader in the advancement of the detection and treatment of prostate cancer, the Smilow Comprehensive Prostate Cancer Center at NYU Langone Medical Center is the first medical facility in the Northeast to install ei-Nav|Artemis™, an innovative image guidance and navigation system for prostate biopsy that is manufactured by Eigen.

25 Feb 2011

Warner Chilcott fourth quarter revenue increases 1% to $694.4 million

Warner Chilcott plc today announced its results for the quarter and year ended December 31, 2010. As discussed more fully below, our financial position and results of operations in the quarter ended December 31, 2010 as compared to the prior year quarter were significantly impacted by several important transactions in 2009 and 2010.

25 Feb 2011

Conceptus announces CE mark approval for use of Transvaginal Ultrasound in Essure procedure

Conceptus Inc., developer of the Essure procedure, the most effective non-surgical permanent birth control method available, today announced receipt of the CE mark for use of Transvaginal Ultrasound to confirm proper placement of Essure micro-inserts three months following the Essure procedure.

24 Feb 2011

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.

From Cell Signaling Technology 24 Feb 2011

Urology News and Research

Latest Urology News and Research

Majority of men on ADT after prostatectomy gain weight during first year of therapy

Surgical robot acquisition increases rate of surgery to treat prostate cancer

State roundup: Concerns about pay for Mass. health executives, board members

TARIS commences LiRIS Phase 1B clinical study in interstitial cystitis

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Vermillion's CA125 positive preliminary data against ovarian tumors presented at WCSGO

Lab made urinary tube going strong after six years of transplant

University of California, Irvine purchase SpineAssist to conduct minimal invasive surgeries

Scientists develop innovative device to efficiently identify CTCs in blood

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Study: Men who consume non-steroidals more likely to have erectile dysfunction

Novabay commences NVC-422 catheter Phase 2 trial to treat UCBE

UH Ahuja Medical Center officially opens its doors to patients on March 2

Robotic surgery offers better results than laparoscopic procedures for kidney disease

Robotic surgery offers favourable outcomes in patients with kidney disease

Endo fourth quarter total revenues increase 31% to $511 million

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

Warner Chilcott fourth quarter revenue increases 1% to $694.4 million

Conceptus announces CE mark approval for use of Transvaginal Ultrasound in Essure procedure

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Urology News and Research

Latest Urology News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in